Continuous Glucose Monitoring Systems Market Products Pipeline for Arkal Medical, Inc., Bio-Impedance General Ltd. and Others

The Pipeline Assessment report on Continuous Glucose Monitoring Systems Market provides the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects. The Continuous Glucose Monitoring Systems Market report analyses more than 50 company’s profiles.

April 24, 2017 /MarketersMedia/ —

The “Continuous Glucose Monitoring Systems Market - Medical Devices Pipeline Assessment, 2017” the report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products.

Browse the 157 Tables and Figures, 70 Companies, Spread across 268 Pages Report Available at http://www.reportsnreports.com/contacts/discount.aspx?name=958615.

Scope of the Report:
Extensive coverage of the Continuous Glucose Monitoring Systems under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Companies are mentioned:
A. Menarini Diagnostics S.r.l., Abbott Diabetes Care, Inc., Advanced Biosensors-Ohio, Llc, Advanced Medical Electronics Corporation, Arkal Medical, Inc., Bio-Impedance General Ltd., Biorasis, Inc., Biovotion AG, CALISTO MEDICAL, INC. (Inactive), Cardiff University Company, City, University of London, Columbia University, ConvaTec Group Plc, Cyber Medical Ltd., Debiotech SA, DexCom Inc, DirectSens GmbH, Echo Therapeutics Inc, Ecole Polytechnique Federale de Lausanne, eLutions Integrated, EyeSense GmbH, Flowsion A/S, Gili Medical Ltd, Globe Medical Tech Inc, and Others.

Place Order to This Report at http://www.reportsnreports.com/purchase.aspx?name=958615.

Continuous Glucose Monitoring Systems Market- Recent Developments :
Mar 30, 2017: ConvaTec Expands Unomedical Manufacturing Technology Partnership with Medtronic Diabetes to Meet Growing Demand
Mar 29, 2017: ConvaTec Group: Directorate changes
Mar 28, 2017: Novo Acquires 19.95% Stake in Convatec from Nordic Capital and Avista for USD1.22 Billion
Mar 28, 2017: ConvaTec: Proposed Directorate Changes
Mar 27, 2017: Integrity Applications Board Appoints John Graham CEO and Chairman, Angela Strand Vice Chairman
Mar 24, 2017: Medicare Announces Criteria Covering Dexcom G5 Mobile CGM for All People with Diabetes on Intensive Insulin Therapy
Mar 21, 2017: Medtronic Prices Public Offering of 1.7% Notes Due 2019 for USD1 Billion
Mar 21, 2017: Medtronic Prices Public Offering of 3.35% Notes Due 2027 for USD850 Million
Mar 21, 2017: Medtronic Prices Public Offering of 4.625% Notes Due 2045 for USD150 Million
Mar 21, 2017: Tenax Therapeutics Announces Year-End 2016 Financial Results and Provides Corporate Update
Mar 14, 2017: PositiveID’s E-N-G Mobile Systems’ 2017 Bookings Through February Total $1.7 Million, Up More than 200% from Prior Quarter
Mar 13, 2017: DexCom Appoints Richard Collins to Board of Directors
Mar 08, 2017: Tandem Diabetes Care Reports 2016 Financial Results
Continuous Glucose Monitoring Systems Market- Recent Developments for 2017, January and February is also mentioned.

List of Tables
Table 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
Table 2: Continuous Glucose Monitoring Systems - Pipeline Products by Segment
Table 3: Continuous Glucose Monitoring Systems - Pipeline Products by Territory
Table 4: Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path
Table 5: Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date
And more

List of Figures
Figure 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
Figure 2: Continuous Glucose Monitoring Systems - Pipeline Products by Territory
Figure 3: Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path
Figure 4: Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date
Figure 5: Continuous Glucose Monitoring Systems - Ongoing Clinical Trials

Complete Table of Content is Available at Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2017.

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Info:
Name: Ritesh Tiwari
Email: [email protected]
Organization: ReportsnReports.com
Phone: + 1 888 391 5441

Source URL: http://marketersmedia.com/continuous-glucose-monitoring-systems-market-products-pipeline-for-arkal-medical-inc-bio-impedance-general-ltd-and-others/189109

For more information, please visit http://www.reportsnreports.com/reports/958615-continuous-glucose-monitoring-systems-medical-devices-pipeline-assessment-2017.html

Source: MarketersMedia

Release ID: 189109